logo

For the Inventor, By the Inventor

Basel, Switzerland

F. Hoffmann-la Roche Ag


USPTO Granted Patents = 168



Trademarks = 4

Forward Citations = 1,425

Loading Chart...
Loading Chart...

402 inventors (with patents filed for the assignee):

goldMedal Adrian Folkes (22 out of 41 patents)

silverMedal Irina Chuckowree (16 out of 23 patents)

bronzeMedal Alan G Olivero (13 out of 46 patents)

4.  Daniel P Sutherlin (13 out of 55 patents)

5.  Nan Chi Wan (12 out of 18 patents)

6.  Bing-Yan Zhu (10 out of 78 patents)

7.  Stephen Joseph Shuttleworth (10 out of 13 patents)

8.  Timothy Colin Hancox (10 out of 12 patents)

9.  Richard A Goldsmith (9 out of 21 patents)

10.  Stephen Colin Price (8 out of 55 patents)

11.  Tim Heffron (8 out of 13 patents)

12.  Helmut Heinrich Buschmann (8 out of 59 patents)

13.  Stephen Cusack (8 out of 13 patents)

14.  Andrea Wolkerstorfer (8 out of 8 patents)

15.  Oliver Szolar (8 out of 8 patents)


Core Competencies:
Prefilled Syringe
CD20-Positive B-Cell Lymphoma
Parkinson's Disease
GPC3-Targeting Drug
Spinal Muscular Atrophy
Camelid Single-Domain Antibody
Bispecific Antibody
High Concentration Antibody
Immunoassay
Combination Therapy
Pharmaceutical Compounds
Phosphoinositide 3-Kinase Inhibitor

168 patents:

1. 12485226 - Prefilled syringe and method of sterilizing a prefilled syringe (2025-12-02),
2. D1101035 - Package leaflet (2025-11-04),
3. D1086453 - Medical bottle adapter (2025-07-29),
4. 12296138 - Prefilled syringe and method of preparing a prefilled syringe (2025-05-13),
5. 12220496 - Prefilled syringe and method of preparing a prefilled syringe (2025-02-11),
6. 12129304 - Treatment of CD20-positive B-cell lymphoma with obinutuzumab (2024-10-29),
7. 12084491 - Treatment of Parkinson's disease (2024-09-10),
8. D1009050 - Display screen with transitional graphical user interface (2023-12-26),
9. D1007526 - Display screen with transitional graphical user interface (2023-12-12),
10. 11760807 - GPC3-targeting drug which is administered to patient responsive to GPC3-targeting drug therapy (2023-09-19),
11. 11753407 - Compounds for treating spinal muscular atrophy (2023-09-12),
12. 11746140 - Composition comprising recombinant GPlbα receptor protein (2023-09-05),
13. 11738106 - Prefilled syringe and method of preparing a prefilled syringe (2023-08-29),
14. 11596620 - Formulations with reduced oxidation (2023-03-07),
15. 11352438 - Methods of using a bispecific antibody that recognizes coagulation factor IX and/or activated coagulation factor IX and coagulation factor X and/or activated coagulation factor X (2022-06-07),
F. Hoffmann-La Roche AG is a multinational healthcare company specializing in pharmaceuticals and diagnostics. Headquartered in Basel, Switzerland, Roche is one of the leading companies in the industry, with a strong focus on research and development. Roche's mission is to improve patients' lives by providing innovative solutions for the prevention, diagnosis, and treatment of diseases. The company's diverse portfolio includes prescription drugs, diagnostic tests, and personalized healthcare solutions. With a global presence, Roche operates in more than 100 countries and employs over 94,000 people worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
168 Patents

#5 in Basel

#99 in Switzerland

#4,777 in the World

...
Basel, Switzerland

F. Hoffmann-la Roche Ag

Forward Citations = 1,425

402 inventors:

goldMedal Adrian Folkes (22 out of 41 patents)

silverMedal Irina Chuckowree (16 out of 23 patents)

bronzeMedal Alan G Olivero (13 out of 46 patents)

4.  Daniel P Sutherlin (13 out of 55 patents)

5.  Nan Chi Wan (12 out of 18 patents)

Please report any incorrect information to support@idiyas.com
Loading…